‘Longevity drug’ rapamycin may have a surprising impact on exercise - The Washington Post

The new midlife exercise study, which links higher fitness in the 40s and 50s to delayed disease and longer healthy life, highlights the tangible benefits of physical activity that could be affected by drugs like rapamycin. High-profile, drug-forward events such as the Enhanced Games—where athletes publicly used performance-enhancing substances and often did not disclose them—underscore the real-world stakes: pharmacological interventions could blunt, alter, or complicate the physiological adaptations produced by exercise. That raises practical concerns about possible trade-offs between longevity drugs and exercise benefits, underscoring the need for studies that directly test how such drugs interact with real-world fitness and health outcomes.